Clinical Trial Update: Long Acting FSH Plus Antagonist Versus Daily FSH Plus Antagonist Versus Short Agonist Protocol in Poor Responders Undergoing IVF [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing three IVF stimulation protocols in poor responders: long-acting FSH with antagonist, daily FSH with antagonist, and a short GnR…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility
• Poor Ovarian Response

Drugs mentioned

• Daily FSH (follitropin alfa)
• GnRH agonist (gonadotropin-releasing hormone agonist)
• GnRH antagonist
• Long-acting FSH (corifollitropin alfa)

Snippet

Sponsor: Bioroma | Conditions: Female Infertility, Poor Responder | Phase 4 | Status: UNKNOWN